MEDICINOVA, INC. Shares Outstanding (Cover Page)
MEDICINOVA, INC. (MNOV) had Shares Outstanding (Cover Page) of 49.22 million shares as of 2026-08-11, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-11: Entity Common Stock, Shares Outstanding 49.22M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 49.22M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 49.22M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 49.05M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 49.22M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 49.22M shares 10-Q · filed 2026-05-14 |
| 2026-03-05 | 49.22M shares 10-K · filed 2026-03-10 |
| 2025-11-12 | 49.05M shares 10-Q · filed 2025-11-12 |
| 2025-08-11 | 49.05M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 49.05M shares 10-Q · filed 2025-05-13 |
| 2025-02-17 | 49.05M shares 10-K · filed 2025-02-19 |
| 2024-11-13 | 49.05M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 49.05M shares 10-Q · filed 2024-08-08 |
| 2024-05-07 | 49.05M shares 10-Q · filed 2024-05-09 |
| 2024-02-12 | 49.05M shares 10-K · filed 2024-02-15 |
| 2023-11-07 | 49.05M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 49.05M shares 10-Q · filed 2023-08-09 |
| 2023-05-09 | 49.05M shares 10-Q · filed 2023-05-11 |
| 2023-02-13 | 49.05M shares 10-K/A · filed 2023-03-28 |
| 2022-11-08 | 49.05M shares 10-Q · filed 2022-11-10 |
| 2022-08-09 | 49.05M shares 10-Q · filed 2022-08-11 |
| 2022-05-12 | 49.05M shares 10-Q · filed 2022-05-12 |
| 2022-02-14 | 49.04M shares 10-K · filed 2022-02-16 |
| 2021-11-09 | 49.04M shares 10-Q · filed 2021-11-12 |
| 2021-08-09 | 48.97M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 48.77M shares 10-Q · filed 2021-05-13 |
| 2021-02-16 | 48.68M shares 10-K · filed 2021-02-19 |
| 2020-10-22 | 44.93M shares 10-Q · filed 2020-10-26 |
| 2020-07-27 | 44.37M shares 10-Q · filed 2020-07-28 |
| 2020-04-21 | 44.07M shares 10-Q · filed 2020-04-23 |
| 2020-02-12 | 43.96M shares 10-K · filed 2020-02-13 |
| 2019-10-23 | 43.84M shares 10-Q · filed 2019-10-24 |
| 2019-07-24 | 43.25M shares 10-Q · filed 2019-07-25 |
| 2019-04-24 | 43.06M shares 10-Q · filed 2019-04-25 |
| 2019-02-12 | 42.17M shares 10-K · filed 2019-02-13 |
| 2018-10-24 | 41.88M shares 10-Q · filed 2018-10-25 |
| 2018-07-20 | 41.88M shares 10-Q · filed 2018-07-23 |
| 2018-04-24 | 41.13M shares 10-Q · filed 2018-04-25 |
| 2018-02-12 | 40.93M shares 10-K · filed 2018-02-13 |
| 2017-10-20 | 36.10M shares 10-Q · filed 2017-10-23 |
| 2017-07-26 | 35.07M shares 10-Q · filed 2017-07-26 |
| 2017-04-26 | 34.54M shares 10-Q · filed 2017-04-26 |
| 2017-02-13 | 34.53M shares 10-K · filed 2017-02-14 |
| 2016-10-21 | 34.49M shares 10-Q · filed 2016-10-25 |
| 2016-07-26 | 34.47M shares 10-Q · filed 2016-07-26 |
| 2016-04-25 | 32.26M shares 10-Q · filed 2016-04-27 |
| 2016-02-18 | 30.00M shares 10-K · filed 2016-02-25 |
| 2015-10-23 | 29.96M shares 10-Q · filed 2015-10-29 |
| 2015-07-24 | 24.89M shares 10-Q · filed 2015-07-30 |
| 2015-05-08 | 24.88M shares 10-Q · filed 2015-05-11 |
| 2015-03-09 | 24.62M shares 10-K · filed 2015-03-12 |
| 2014-11-07 | 24.22M shares 10-Q · filed 2014-11-13 |
| 2014-08-08 | 24.15M shares 10-Q · filed 2014-08-13 |
| 2014-05-06 | 24.15M shares 10-Q · filed 2014-05-08 |
| 2014-03-27 | 24.07M shares 10-K · filed 2014-03-27 |
| 2013-11-06 | 22.40M shares 10-Q · filed 2013-11-07 |
| 2013-08-07 | 22.31M shares 10-Q · filed 2013-08-08 |
| 2013-05-07 | 19.67M shares 10-Q · filed 2013-05-08 |
| 2013-03-27 | 18.24M shares 10-K · filed 2013-03-28 |
| 2012-11-07 | 17.20M shares 10-Q · filed 2012-11-08 |
| 2012-08-08 | 16.16M shares 10-Q · filed 2012-08-09 |
| 2012-05-09 | 16.19M shares 10-Q · filed 2012-05-10 |
| 2012-03-27 | 16.09M shares 10-K · filed 2012-03-29 |
| 2011-11-09 | 16.09M shares 10-Q · filed 2011-11-14 |
| 2011-08-10 | 15.29M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |